Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Kynam Capital Management, LP reported a 9.96% stake in Cytomx Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Kynam Capital Management, LP reported a 9.96% stake in Cytomx Therapeutics, Inc., 0 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.96%
- Shares
- 0
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Kynam Capital Management, LP | 9.96% | 0 |
| Kynam Capital Management GP, LLC | 9.96% | 0 |
| Yue Tang | 9.96% | 0 |
Source
Related
- Cytomx Therapeutics, Inc.
- Kynam Capital Management, LP
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G/A · Kynam Capital Management, LP · May 15, 2026
- Schedule 13G · Kynam Capital Management, LP · Mar 4, 2026
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026